Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
The present study aimed to establish population pharmacokinetic models of latamoxef, as well as its R- and S-epimers, and generate findings to guide the individualized administration of latamoxef in pediatric patients. A total of 145 in-hospital children aged 0.08-10.58 years old were included in th...
Saved in:
Main Authors: | Yang Wang (Author), Dan Sun (Author), Yan Mei (Author), Sanlan Wu (Author), Xinlin Li (Author), Sichan Li (Author), Jun Wang (Author), Liuliu Gao (Author), Hua Xu (Author), Yali Tuo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Latamoxef dosing regimen adjustments and pharmaceutical care in pediatrics
by: Ailin Zhang, et al.
Published: (2024) -
Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
by: SiChan Li, et al.
Published: (2021) -
Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024) -
Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
by: Liuliu Gao, et al.
Published: (2020) -
Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children
by: Xianhuan Shen, et al.
Published: (2024)